ACE2, the cellular receptor for SARS-CoV-2 [40, 42], undergoes shedding, leading to circulating ACE2, a biomarker of cardiovascular disease, diabetes, and death in patients with and without COVID-19 [52, 53]. This evidence concerns the gene ACE2 and COVID-19.